Krm Ayurveda Ipo
KRM Ayurveda IPO Review & Key Points
Review: May Apply
IPO Lead Managers aka Merchant Bankers
NEXGEN Financial Solutions Pvt. Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,000 | ₹2,70,000 |
| Retail Maximum | 2 | 2,000 | ₹2,70,000 |
| S-HNI Minimum | 3 | 3,000 | ₹4,05,000 |
| S-HNI Maximum | 7 | 7,000 | ₹9,45,000 |
| B-HNI Minimum | 8 | 8,000 | ₹10,80,000 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 15,42,000 Shares | 26.86% |
| QIB (Ex. Anchor) | 10,32,000 Shares | 17.98% |
| NII Shares Offered | 7,80,000 Shares | 13.59% |
| Retail Shares Offered | 18,12,000 Shares | 31.57% |
| Anchor Bidding Date | January 20, 2026 |
| Anchor Investors List | |
| Shares Offered | 15,42,000 Shares |
| Anchor Size | 20.82 Cr. |
| lock-in period end date 50% shares (30 Days) | February 26, 2026 |
| lock-in period end date 50% shares (90 Days) | April 27, 2026 |
| IPO Open Date: | January 21, 2026 |
| IPO Close Date: | January 23, 2026 |
| Basis of Allotment: | January 27, 2026 |
| Refunds: | January 28, 2026 |
| Credit to Demat Account: | January 28, 2026 |
| IPO Listing Date: | January 29, 2026 |
| IPO Bidding Cut-off Time: | January 23, 2026 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 1,55,20,800 | 92.16% |
| Promoter Holding Post Issue | 2,12,60,800 | 67.28% |
| Purpose | Crores |
| Capital Expenditure for Construction and Development of Telemedicine Operational Facilities | ₹13.67 |
| Purchase of CRM Software and Hardware Infrastructure | ₹1.42 |
| Human Resources | ₹5.44 |
| Repayment/Prepayment of loan | ₹12.50 |
| Working Capital Requirement | ₹18.00 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹89.38 | ₹79.29 | ₹7.60 | ₹39.48 |
| 2024 | ₹67.57 | ₹62.85 | ₹3.41 | ₹43.91 |
| 2025 | ₹76.95 | ₹60.61 | ₹12.10 | ₹66.79 |
| Sep 2025 | ₹48.65 | ₹37.65 | ₹8.14 | ₹78.12 |
| KPI | Values |
| ROE: | 67.86% |
| ROCE: | 43.33% |
| EBITDA Margin: | 24.96% |
| PAT Margin: | 15.80% |
| Debt to equity ratio: | 1.31 |
| Earning Per Share (EPS): | ₹8.06 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 67.86% |
| Net Asset Value (NAV): | ₹1,602.40 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Jeena Sikho Lifecare Ltd. | 8.86 | 76.58 | 31.28% | 142.24 | 110.10 Cr. |
| Vaidya Sane Ayurved Laboratories Ltd | 3.07 | 93.20 | 5.12% | 59.85 | 3.22 Cr. |
| IPO Open Date | January 21, 2026 |
| IPO Close Date | January 23, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹128 to ₹135 Per Share |
| Issue Size | Approx ₹77.49 Crores |
| Fresh Issue | Approx ₹77.49 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |